BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31337024)

  • 41. Zerumbone induces G2/M cell cycle arrest and apoptosis via mitochondrial pathway in Jurkat cell line.
    Rahman HS; Rasedee A; Chartrand MS; Othman HH; Yeap SK; Namvar F
    Nat Prod Commun; 2014 Sep; 9(9):1237-42. PubMed ID: 25918781
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.
    Shan D; Li J; Cai P; Prasad P; Liu F; Rauth AM; Wu XY
    Drug Deliv Transl Res; 2015 Feb; 5(1):15-26. PubMed ID: 25787336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Zerumbone suppresses IL-1β-induced cell migration and invasion by inhibiting IL-8 and MMP-3 expression in human triple-negative breast cancer cells.
    Han J; Bae SY; Oh SJ; Lee J; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Nam SJ; Kim S; Lee JE
    Phytother Res; 2014 Nov; 28(11):1654-60. PubMed ID: 24890258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro effects on proliferation, apoptosis and colony inhibition in ER-dependent and ER-independent human breast cancer cells by selected mushroom species.
    Gu YH; Leonard J
    Oncol Rep; 2006 Feb; 15(2):417-23. PubMed ID: 16391863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved Anticancer Effect of Recombinant Protein izTRAIL Combined with Sorafenib and Peptide iRGD.
    Fadeev R; Chekanov A; Solovieva M; Bezborodova O; Nemtsova E; Dolgikh N; Fadeeva I; Senotov A; Kobyakova M; Evstratova Y; Yakubovskaya R; Akatov V
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential mRNA expression in the induction of DNA damage, G
    Rondina DBL; de Lima LVA; da Silva MF; Zanetti TA; Felicidade I; Marques LA; Coatti GC; Mantovani MS
    Toxicol In Vitro; 2022 Dec; 85():105474. PubMed ID: 36122806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regression of cervical intraepithelial neoplasia by zerumbone in female Balb/c mice prenatally exposed to diethylstilboestrol: involvement of mitochondria-regulated apoptosis.
    Abdelwahab SI; Abdul AB; Devi N; Taha MM; Al-zubairi AS; Mohan S; Mariod AA
    Exp Toxicol Pathol; 2010 Sep; 62(5):461-9. PubMed ID: 19581075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dietary zerumbone from shampoo ginger: new insights into its antioxidant and anticancer activity.
    Rosa A; Caprioglio D; Isola R; Nieddu M; Appendino G; Falchi AM
    Food Funct; 2019 Mar; 10(3):1629-1642. PubMed ID: 30834410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Co-administration of kla-TAT peptide and iRGD to enhance the permeability on A549 3D multiple sphere cells and accumulation on xenograft mice.
    Hu C; Chen X; Huang Y; Chen Y
    Chem Biol Drug Des; 2018 Aug; 92(2):1567-1575. PubMed ID: 29722179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Zerumbone, a Southeast Asian ginger sesquiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: the alpha,beta-unsaturated carbonyl group is a prerequisite.
    Murakami A; Takahashi D; Kinoshita T; Koshimizu K; Kim HW; Yoshihiro A; Nakamura Y; Jiwajinda S; Terao J; Ohigashi H
    Carcinogenesis; 2002 May; 23(5):795-802. PubMed ID: 12016152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. α
    Zhong P; Gu X; Cheng R; Deng C; Meng F; Zhong Z
    Int J Nanomedicine; 2017; 12():7913-7921. PubMed ID: 29138558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Review of the Biomedical Applications of Zerumbone and the Techniques for Its Extraction from Ginger Rhizomes.
    Kalantari K; Moniri M; Boroumand Moghaddam A; Abdul Rahim R; Bin Ariff A; Izadiyan Z; Mohamad R
    Molecules; 2017 Sep; 22(10):. PubMed ID: 28974019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.
    Gao F; Zhang J; Fu C; Xie X; Peng F; You J; Tang H; Wang Z; Li P; Chen J
    Int J Nanomedicine; 2017; 12():4147-4162. PubMed ID: 28615942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Zerumbone induces mitochondria-mediated apoptosis via increased calcium, generation of reactive oxygen species and upregulation of soluble histone H2AX in K562 chronic myelogenous leukemia cells.
    Rajan I; Jayasree PR; Kumar PR
    Tumour Biol; 2015 Nov; 36(11):8479-89. PubMed ID: 26026585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination of zerumbone and cisplatin to treat cervical intraepithelial neoplasia in female BALB/c mice.
    Abdul AB; Abdelwahab SI; Bin Jalinas J; Al-Zubairi AS; Taha MM
    Int J Gynecol Cancer; 2009 Aug; 19(6):1004-10. PubMed ID: 19820360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells.
    Huang MB; Gonzalez RR; Lillard J; Bond VC
    Oncotarget; 2017 Feb; 8(7):11302-11315. PubMed ID: 28076321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and evaluation of new iRGD peptide analogs for tumor optical imaging.
    Ye Y; Zhu L; Ma Y; Niu G; Chen X
    Bioorg Med Chem Lett; 2011 Feb; 21(4):1146-50. PubMed ID: 21251820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liquid chromatography-tandem mass spectroscopic method for the determination of zerumbone in human plasma and its application to pharmacokinetics.
    Eid EE; Abdul AB; Rasedee A; Suliman FE; Sukari MA; Fatah SA
    J Mass Spectrom; 2011 Aug; 46(8):772-81. PubMed ID: 21834015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modification of IL-24 by tumor penetrating peptide iRGD enhanced its antitumor efficacy against non-small cell lung cancer.
    Yang J; Yang J; Wei Y; Yin H; Fang L; Chai D; Li H; Li H; Zhang Q; Zheng J
    Int Immunopharmacol; 2019 May; 70():125-134. PubMed ID: 30798161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunomodulatory and enhanced antitumor activity of a modified thymosin α1 in melanoma and lung cancer.
    Wang F; Li B; Fu P; Li Q; Zheng H; Lao X
    Int J Pharm; 2018 Aug; 547(1-2):611-620. PubMed ID: 29933059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.